Impact of Day 14 Bone Marrow Biopsy on Re-Induction Decisions and Prediction of a Complete Response in Acute Myeloid Leukemia Cases

BACKGROUND: With acute myeloid leukemia (AML), there are limited data about the accuracy of day 14 bone marrow (BM) biopsies for predicting complete remission as compared to day 28 BM biopsy results. We here aimed to estimate the correlation between, and the diagnostic accuracy of, both approaches....

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Asian Pac J Cancer Prev
Egile Nagusiak: Alsaleh, Khalid, Aleem, Aamer, Almomen, Abdulkareem, Anjum, Farhan, Alotaibi, Ghazi S
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: West Asia Organization for Cancer Prevention 2018
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5980929/
https://ncbi.nlm.nih.gov/pubmed/29479992
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.22034/APJCP.2018.19.2.421
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak